Cardiovascular disease remains the foremost cause of morbidity and mortality globally, affecting millions of individuals. Recent discoveries illuminate the substantial role of genetics in ...

Medically reviewed by Christopher Lee, MD Coronary artery disease (CAD) occurs when the arteries (heart's blood vessels) ...

H.C. Wainwright lowered the firm’s price target on Verve Therapeutics (VERV) to $14 from $15 and keeps a Buy rating on the shares after ...

Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Verve Therapeutics (VERV – Research Report) and decreased the ...

Heterozygous familial hypercholesterolemia was associated with increased type 2 diabetes risk, especially among those with obesity and statin use.

As it approaches the one-year anniversary of its efforts to study how DNA can be used to help identify certain health ...

BOSTON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today reported pipeline updates and ...

Simarjot Singh Judge, 36, was diagnosed with familial hypercholesterolaemia in June 2022, a condition which makes him 'a cholesterol-making machine' ...

A new survey shows that three Big Pharmas have stolen the hearts of patient groups representing nearly 1 million people with cardiovascular conditions. | A new survey shows that three Big Pharmas have ...

A half-dozen hospital systems plan to implement the tool, which combs through patient medical records to identify those ...